Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereof

Dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereof

US Patent 11905293 · Granted Feb 20, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dual mode of action soluble guanylate cyclase activators and phosphodiesterase i2025
Dual mode of action soluble guanylate cyclase activators and phosphodiesterase i2025
2-phenyl-3,4-dihydropyrrolo[2,1-f] [1,2,4]triazinone derivatives as phosphodiest2025
2-phenyl-3,4-dihydropyrrolo[2,1-f] [1,2,4]triazinone derivatives as phosphodiest2025
2-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodies2024
2-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodies2024
2-phenyl-3,4-dihydropyrrolo[2,1-Ff] [1,2,4]triazinone derivatives as phosphodies2022
2-phenyl-3,4-dihydropyrrolo[2,1-Ff] [1,2,4]triazinone derivatives as phosphodies2022
Dual mode of action soluble guanylate cyclase activators and phosphodiesterase i2021
Dual mode of action soluble guanylate cyclase activators and phosphodiesterase i2021
2-phenyl-3,4-dihydropyrrolo[2,1 -F] [1,2,4]triazinone derivatives as phosphodies2020
2-phenyl-3,4-dihydropyrrolo[2,1 -F] [1,2,4]triazinone derivatives as phosphodies2020